CRBU - CIK 0001619856
Caribou Biosciences, Inc. (CRBU) reported net income of -$148.13M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$148.13M | +0.7% |
| FY 2024 | -$149.10M | -46.1% |
| FY 2023 | -$102.07M | -2.7% |
| FY 2022 | -$99.42M | -48.6% |
| FY 2021 | -$66.92M | -95.1% |
| FY 2020 | -$34.31M | -46.4% |
| FY 2019 | -$23.43M | - |
Caribou Biosciences, Inc. (CRBU) reported net income of -$148.13M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Caribou Biosciences, Inc.'s net income declined from -$23.43M to -$148.13M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.